Molika Ashford
Articles
-
2 days ago |
genomeweb.com | Molika Ashford
NEW YORK – New research presented this week at the annual meeting of the American Society for Clinical Oncology showcased some early efforts to use liquid biopsy testing to adapt cancer treatment in real time, in this case in patients with head and neck tumors.
-
2 days ago |
genomeweb.com | Molika Ashford
NEW YORK – This year's annual meeting of the American Society of Clinical Oncology featured new data from a slew of test developers advancing multi-cancer early detection (MCED) technologies, alongside tactful discussion including oncologists and patient advocates acknowledging continued uncertainty about the true utility of these assays.
-
3 days ago |
genomeweb.com | Molika Ashford
NEW YORK – New data presented this week at the annual meeting of the American Society of Clinical Oncology in Chicago has set the stage for the potential future use of molecular residual disease testing to prognosticate and personalize treatment of cervical cancer.
-
4 weeks ago |
360dx.com | Molika Ashford
NEW YORK – Multi-cancer early detection (MCED) firm Grail published a new study on Thursday that expands on earlier modeling work to analyze the impact of different testing intervals on the ability of its Galleri circulating tumor DNA (ctDNA) assay to shift cancer diagnoses across a population to earlier, more treatable stages.
-
4 weeks ago |
genomeweb.com | Molika Ashford
NEW YORK – Multi-cancer early detection (MCED) firm Grail published a new study on Thursday that expands on earlier modeling work to analyze the impact of different testing intervals on the ability of its Galleri circulating tumor DNA (ctDNA) assay to shift cancer diagnoses across a population to earlier, more treatable stages.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →X (formerly Twitter)
- Followers
- 136
- Tweets
- 31
- DMs Open
- No
Thanks @EricTopol. Important to watch how inst. like @MDAndersonNews do making case to payors. @GenomeWeb @WiredUK @drjmedeiros
RT @molquant: #PMWC16 "will cfDNA work for #earlycancerdetection?" "It's an extremely difficult problem, but could save more lives than dr…
Liquid biopsy at #PMWC16 - no conference room is large enough to handle it.
